FDA Clearance Tracker · P050020-S022
FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEM
Last checked: Nov 20, 2026Latest source record: Jan 14, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2011
Approved
Time to decision
346 days
Received Feb 2, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P050020-S022
- Device name
- FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEM
- Applicant
- Abbott Laboratories
- Applicant location
- Alameda, CA
- Received
- Feb 2, 2010
- Decided
- Jan 14, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Original approval
- P050020
Device type
- Device type
- Sensor, glucose, invasive (MDS)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CHANGES TO THE OUTGOING QUALITY CONTROL (QC) SOLUTION TESTING.
Source documents
Other decisions for Abbott Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Anti-HCV Next510(k)
K262156 · Decided Sep 23, 2026 · 89 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.